Dow Jones Falls 100 Points As McConnell Says No To Schumer; 8 Blue-Chip Stocks Near Buy Points

The Dow Jones Industrial Average, S&P 500 and Nasdaq composite were off session highs in afternoon trading Tuesday, with three trading days left in 2020. Apple stock scored an all-time high in the Dow Jones today, while Chinese stocks like Pinduoduo (PDD), (JD) and Baidu (BIDU) outperformed in the Nasdaq 100.


Baidu stock continues to show bullish technical action, trading tightly and holding near highs after soaring 19.5% during the week ended Dec. 18.

Small caps fared the worst, with the Russell 2000 down 2%. But after eight straight weekly gains for the small-cap index, some consolidation should be expected. Selling was more muted in the broad market, with the Dow Jones industrials, S&P 500 and Nasdaq composite down 0.1% to 0.3% at around 1:33 p.m. ET. Volume on the NYSE and Nasdaq was lower compared with the same time Monday.

The stock market weakened a bit after Senate Majority Leader Mitch McConnell blocked an attempt by Senate Minority Leader Chuck Schumer to unanimously approve $2,000 coronavirus-aid stimulus checks cleared Monday by the Democrat-controlled House.

U.S. Stock Market Today Overview

Index Symbol Price Gain/Loss % Change
Dow Jones (0DJIA) 30300.33 -103.64 -0.34
S&P 500 (0S&P5) 3728.41 -6.95 -0.19
Nasdaq (0NDQC ) 12851.45 -47.97 -0.37
Russell 2000 (IWM) 193.87 -4.40 -2.22
IBD 50 (FFTY) 40.29 -0.58 -1.42
Last Update: 1:12 PM ET 12/29/2020

The Nasdaq composite is a little stretched at 7% above its moving average. A market pullback could come at any time, but the distribution day count for the S&P 500 and Nasdaq is still relatively light, with four distribution days on the S&P 500 and three on the Nasdaq. Of the S&P 500’s four distribution days, three showed mild declines of 0.3% to 0.5%. Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.

Dow Jones Stocks To Watch

Amid plenty of calls for a stock market pullback, there’s no shortage of stocks in the Dow Jones that could be poised for upside breakouts.

Apple (AAPL) backed off highs after hitting an all-time high of 138.06. Shares were strong early on bullish comments from Gene Munster, a top Apple analyst. Apple joined Leaderboard on Dec. 1 when it broke out over a trend line. It cleared an alternate proper entry of 125.49 when it gapped up on Dec. 15.

JPMorgan (JPM) is still in buy range from a 123.60 handle entry on a long, deep consolidation. Financial stocks have been buoyed by rising Treasury yields and widening Treasury spreads. JPMorgan reports earnings on January 15, along with Citigroup (C), PNC Financial Services (PNC) and Wells Fargo (WFC).

Join IBD experts as they analyze leading stocks in the stock market rally on IBD Live

Visa (V) looked poised for its third straight gain, up 1% to 214.75, as it forms a flat base with a 217.75 buy point. Please read this Visa piece for more CAN SLIM analysis.

American Express (AXP) gapped up on Nov. 9 and has done a good job holding gains since then. It still has a ways to go to get to an alternate buy point at 125.42, 10 cents above its Dec. 4 intraday high.

Coronavirus vaccine stock Johnson & Johnson (JNJ) is near the top of a long consolidation with a 155.20 buy point.

Coca-Cola (KO) is in a bullish technical setup as it sits just below a 54.72 buy point. Microsoft (MSFT) and Travelers (TRV) aren’t far from buy points, either.

IBD 50 Movers

Growth stocks were under pressure for a second straight session Tuesday. After falling nearly 2% Monday, the Innovator IBD 50 ETF (FFTY) was down an additional 1.3%, weighed down by weakness in Digital Turbine (APPS), Smith & Wesson (SWBC), Chegg (CHGG) and Trade Desk (TTD). (AMZN) outperformed in the IBD 50, up 1.5%, after a breakout over a trend line Monday.

Inside the MarketSmith Growth 250, several leading biotech stocks came under intense selling pressure. Editas Medicine (EDIT), Intellia Therapeutics (NTLA), Ultragenyx Pharmaceutical (RARE) and Twist Bioscience (TWST) showed losses ranging from 12% to 14%.

Follow Ken Shreve on Twitter @IBD_KShreve for more stock market analysis and insight.


Top Growth Stocks To Buy And Watch

Stay In Sync With The Market With IBD’s ETF Market Strategy

Find The Best Long-Term Investments With IBD Long-Term Leaders

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today